Supporting the Implementation of Precision Medicine.
Precision Rx-Dx Inc. is an international consultancy, based in Canada, formed to support companies during launch of their Precision Medicines and the associated biomarkers.
Precision Rx-Dx Inc. is an international consultancy, based in Canada, formed to support companies during launch of their Precision Medicines and the associated biomarkers.
Providing deep expertise to adapt regional strategies for companion diagnostics and biomarkers to optimize launches of precision medicines
Our focus is to provide consultation and support to our clients in refining their global strategies as well as building local market and organizational readiness. Our team of experts have an extensive knowledge of the CDx and biomarker landscape and the rapidly evolving policies and practices.
This ensures a robust launch and accelerated adoption of both the targeted therapeutic and the associated biomarker.
Precision’s programs are developed to address the multidisciplinary requirement of this field and we are very experienced in facilitating dialogue and stakeholder collaboration to manage change in the marketplace.
Many of Precision’s programs culminate in the development of best practice publications, including clinical and testing algorithms for new companion diagnostics and biomarkers.
Our core team comprises seasoned experts many with over 25 years of experience in diagnostic and/or pharmaceutical development. We are champions in facilitating dialogue and stakeholder collaboration to manage change and drive progress in the marketplace.
Our core team cover the following areas:
Principal and Co-Founder
Educated in genetic engineering and biotechnology, Monette’s career has centered on the development and successful market adoption of life science and diagnostic innovation. Monette has lived and worked internationally with growth mandates in the pharma biomarker development area, and hospital and community lab sectors. With over 25 years of executive experience her past roles include global President/Vice President positions with Thermo Fisher Scientific and Executive Commercial/Government relations’ roles with LifeLabs Medical Laboratories, Strategic Diagnostics and Mount Sinai Services.
Principal and Co-Founder
Ann has over 30 years of executive experience in the healthcare industry and brings hands-on market launch expertise and knowledge across many therapeutic and diagnostic categories. Ann started her career with J&J at Ortho Diagnostics here in Canada and was responsible for the development and launch of new diagnostic products both in Canada and internationally. Her extensive pharmaceutical experience includes her role on the Executive Management Board of Janssen-Ortho as VP Marketing and Sales, Biotech/Oncology and New Product Development. Ann was responsible for the launch of many speciality therapeutics products.
Our work speaks through our contributions to best practice publications and clinical testing algorithms. Explore our recent thought leadership support in the field of Precision Medicine.
We are committed to responding promptly and efficiently to your needs.